Kwality Pharmaceuticals
Kwality Pharmaceuticals Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Kwality Pharmaceuticals
Start SIPKwality Pharmaceuticals Investment Rating
-
Master Rating:
-
M K Proteins has an operating revenue of Rs. 917.88 Cr. on a trailing 12-month basis. An annual revenue de-growth of -18% needs improvement, Pre-tax margin of 5% is okay, ROE of 25% is exceptional. The company has a reasonable debt to equity of 7%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 168% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 10% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 76 which is a FAIR score but needs to improve its earnings, a RS Rating of 99 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 156 indicates it belongs to a poor industry group of Food-Packaged and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 56 | 56 | 70 | 64 |
| Operating Expenses Qtr Cr | 41 | 40 | 52 | 48 |
| Operating Profit Qtr Cr | 15 | 16 | 18 | 16 |
| Depreciation Qtr Cr | 4 | 4 | 3 | 3 |
| Interest Qtr Cr | 2 | 1 | 1 | 1 |
| Tax Qtr Cr | 3 | 2 | 4 | 4 |
| Net Profit Qtr Cr | 7 | 9 | 11 | 10 |
Kwality Pharmaceuticals Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 5
- Bearish Moving Average
- ___
- 11
- 20 Day
- 320.35
- 50 Day
- 333.15
- 100 Day
- 346.78
- 200 Day
- 370.07
- 20 Day
- 320.52
- 50 Day
- 335.6
- 100 Day
- 345.67
- 200 Day
- 352.23
Kwality Pharmaceuticals Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 318.42 |
| Second Resistance | 322.09 |
| Third Resistance | 324.22 |
| RSI | 44.98 |
| MFI | 34.85 |
| MACD Single Line | -7.46 |
| MACD | -6.55 |
| Support | |
|---|---|
| First Resistance | 312.62 |
| Second Resistance | 310.49 |
| Third Resistance | 306.82 |
Kwality Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 1,695 | 110,599 | 65.25 |
| Week | 4,220 | 342,310 | 81.12 |
| 1 Month | 5,847 | 442,636 | 75.7 |
| 6 Month | 16,593 | 1,198,365 | 72.22 |
Kwality Pharmaceuticals Result Highlights
Kwality Pharmaceuticals Synopsis
NSE-Food-Packaged
M K Proteins belongs to the Industry of Edible Oils & Solvent Extraction. Company’s Total Operating Revenue is Rs. 255.89 Cr. and Equity Capital is Rs. 4.17 Cr. for the Year ended 31/03/2022. M K Proteins Ltd. is a Public Limited Listed company incorporated on 15/06/2012 and has its registered office in the State of Haryana, India. Company’s Corporate Identification Number(CIN) is L15500HR2012PLC046239 and registration number is 046239.| Market Cap | 913 |
| Sales | 256 |
| Shares in Float | 0.31 |
| No of funds | |
| Yield |
| Book Value | 23.3 |
| U/D Vol ratio | 2 |
| LTDebt / Equity | 7 |
| Alpha | 1.71 |
| Beta | 0.2 |
Kwality Pharmaceuticals
| Owner Name | Feb-23 | Sep-22 |
|---|---|---|
| Promoters | 74.82% | 74.82% |
| Individual Investors | 11.45% | 10.94% |
| Others | 13.73% | 14.24% |
Kwality Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Vinod Kumar | Managing Director & CEO |
| Mr. Raj Kumar | Whole Time Director |
| Mr. Parvind Kumar | Non Executive Director |
| Mr. Parmod Kumar | Non Executive Director |
| Mr. Chatter Singh | Ind. Non-Executive Director |
| Mr. Raman Kumar Sah | Ind. Non-Executive Director |
| Mr. Abhay Kumar | Ind. Non-Executive Director |
| Mr. Dinesh Singh Malik | Ind. Non-Executive Director |
| Ms. Laxmi Mandal | Ind. Non-Executive Director |
Kwality Pharmaceuticals Forecast
Price Estimates
Kwality Pharmaceuticals FAQs
What is Share Price of Kwality Pharmaceuticals ?
Kwality Pharmaceuticals share price is ₹317 As on 24 March, 2023 | 21:18
What is the Market Cap of Kwality Pharmaceuticals ?
The Market Cap of Kwality Pharmaceuticals is ₹328.9 Cr As on 24 March, 2023 | 21:18
What is the P/E ratio of Kwality Pharmaceuticals ?
The P/E ratio of Kwality Pharmaceuticals is 8.7 As on 24 March, 2023 | 21:18
What is the PB ratio of Kwality Pharmaceuticals ?
The PB ratio of Kwality Pharmaceuticals is 1.8 As on 24 March, 2023 | 21:18